Pragma Bio
PrivateLast Round
Series A
Mar 23, 2023
Total Funding Raised
$14.5M
Company Overview
Pragma Bio operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in March 2023.
Pragma Bio is a biotechnology company that uses an AI-powered platform and synthetic biology to discover and develop small molecule medicines derived from the human gut microbiome for immunological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pragma Bio Comparables
Compare Pragma Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wild Biotech | 82% | |
| Hexagon Bio | 82% | |
| Persephone Biosciences | 82% |
For institutional investors. Book with your work email.
Pragma Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2023 | ||||
| Seed | Dec 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pragma Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CJ Investment | Seed |
| Viking Global Investors | Series A, Seed |
| The Venture Collective | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2023
$10M round led by The Venture Collective.
- Dec 15, 2020
$5M round led by Viking Global Investors
For institutional investors. Book with your work email.
Pragma Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pragma Bio's valuation, stock price, and market status.
Is Pragma Bio a public or private company?
Pragma Bio is a private company.
What is the current stock price of Pragma Bio?
Pragma Bio is a private company, so its shares have no public market price. Caplight tracks Pragma Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pragma Bio worth (valuation)?
Valuation information for Pragma Bio is not publicly available.
Can I buy Pragma Bio stock?
Pragma Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pragma Bio's last funding round?
Pragma Bio's most recent funding round was Series A on March 23, 2023.
Who are the main investors in Pragma Bio?
Key investors in Pragma Bio include Viking Global Investors, The Venture Collective.
Will Pragma Bio IPO soon?
No public IPO plans have been announced for Pragma Bio.
How can I track Pragma Bio secondary market activity?
Caplight tracks bids, offers, and trades in Pragma Bio's shares on secondary markets.